Compugen and Biosite Announce Diagnostic Collaboration

Both companies announced today a collaboration for the development and commercialization of diagnostic products. Under the agreement, Biosite is licensed to develop and commercialize immunoassay based diagnostic products using novel biomarkers discovered by Compugen. Using its genomic platform and other proprietary computational tools, Compugen is expected to provide Biosite with comprehensive data on several gene targets to be nominated by Biosite.

Compugen and Biosite Announce Diagnostic Collaboration

1 comment:

Diagnostic Products said...

We are suppliers of Diagnostic Products ,offered at discount prices.

Blog Archive